Funding Update
UFHCC & Extramural Opportunities
UFHCC Opportunities
UFHCC Bridge Grant Program
The UFHCC Bridge Grant Program is designed to support promising new research or competitive renewals that have nearly missed funding pay lines. The research must have strong cancer relevance; clinical, basic and population research grants are all acceptable.
For NCI and other cancer-focused NIH proposals, applications that have been scored or ranked within 5% of the Institute’s published funding pay line will receive automatic bridge funding from the cancer center. Full-time UFHCC faculty members in Gainesville may apply. Newly recruited Assistant Professors are eligible to apply, whereas newly recruited senior faculty with start-up packages from the cancer center are not eligible.
AWARD AMOUNT & DURATION:
- The maximum award for these grants is $75,000 direct cost for R01s and $50,000 for R21s. No IDC is allowed.
- The award is for a period of one year and all funds are expected to be expended during that term.
Applications will be accepted on a rolling basis. Applicants should submit their full Federal proposal with a screenshot of their score/percentile to ResearchAdmin@cancer.ufl.edu. LEARN MORE.
UFHCC Pilot Project Awards
The UF Health Cancer Center offers funding for pilot projects to encourage new collaborative cancer research. Such interactions can bring new and exciting directions that focus on new collaborations and new lines of research. The purpose of this mechanism is to provide developmental support for promising cancer-focused research projects that propose innovative research across multiple disciplines for a better understanding of the biology, etiology, detection, prevention, treatment, and control of cancer.
The goals of the UFHCC Pilot Project Awards are to:
- Provide developmental support for promising cancer-focused collaborative research projects with a well-defined major objective or theme;
- Create synergies and lasting collaborations between cancer researchers that will lead to impactful publications and stimulate collaborative grant applications for future Federal or other peer-reviewed extramural cancer research funding.
LOIs are due by October 23, 2017 and should be emailed to ResearchAdmin@cancer.ufl.edu. All LOIs will be administratively reviewed for eligibility and scientifically promising projects will be invited to submit full proposals. LEARN MORE.
Extramural Opportunities
The following is a list of new cancer-focused extramural funding opportunities. To stay updated throughout the month, please visit our website.
American Lung Association
Biomedical Research Grant — Application due date: 12/15/17
Clinical Patient Care Research Grant — Application due date: 12/21/17
Social-Behavioral Research Grant —Application due date: 12/21/17
Dalsemer Research Grant — Application due date: 12/15/17
Lung Health Dissertation Grant — Application due date: 12/21/17
Senior Research Training Fellowship — Application due date: 12/21/17
Rivkin Center for Ovarian Cancer
Bridge Funding — Application due date: 10/15/17
Scientific Scholar — Application due date: 12/1/17
Pilot Study — Application due date: 12/1/17
National Institutes of Health
Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01-Clinical Trial Not Allowed) — Application due date: 11/15/2017
Pediatric Immunotherapy Discovery and Development Network (PI-DDN) (U01) (U54) LOI due date: 11/17/2017 — Application due date: 12/19/17
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01) (R21) — Application due date: 11/27/17
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed)
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01 Clinical Trial Not Allowed) (R21 Clinical Trial Not Allowed) — Application due date: 12/4/17
Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01) — LOI due date: 12/9/17 Application due date: 1/9/18
“High” or “Medium” Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) (R21) — Application due date: 1/7/2018
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01) — Application due date: 2/5/18
Research on the Health of Transgender and Gender Nonconforming Populations (R01) (R21) — Application due date: 2/18/18
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)— Application due date: 3/6/18
When Everyone Survives Foundation
Proposals for Innovative Research in Leukemia — Application due date: 4/1/18
